Histologic transformation to small cell lung cancer (SCLC) is a widely known resistance mechanism to epidermal growth factor receptor (EGFR) targeted therapy in Non-Small Cell Lung Cancer (NSCLC) occurring in 3-15% of EGFR aberrated NSCLC20. This evidence concerns the gene EGFR and non-small cell lung carcinoma.